Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in Japanese patients with type 2 diabetes mellitus.

Yukihiro Bando, Hitomi Tohyama,Keiko Aoki,Hideo Kanehara,Azusa Hisada,Kazuhiro Okafuji,Daisyu Toya

Journal of Clinical & Translational Endocrinology（2016）

引用 20|浏览12

暂无评分

摘要

•Small dense LDL-C (sd LDL-C) convey cardiovascular risk in type 2 diabetes (T2D).•Ipragliflozin reduced sd LDL-C levels in Japanese patients with T2D.•Changes in body weight, TG and LDL-C levels contributed to sd LDL-C reduction.

查看译文

关键词

Small dense LDL cholesterol,Ipragliflozin,Type 2 diabetes mellitus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要